Form 10-K ARRHYTHMIA RESEARCH TECH For: Dec 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500, Nasdaq futures rise on tech boost
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Oil rises on Iran war stalemate; near-term potential for further gains seen limited
- L3Harris CEO steps down amid conduct review, shares drop
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
- BOJ eyeing September rate hike, faster pace of tightening, sources say
Arrhythmia Research Technology (HRT) Swings to Q4 Profit
March 20, 2015 8:00 AM EDTArrhythmia Research Technology (NYSE: HRT) reported Q4 EPS of $0.01, versus ($0.03) reported last year. Revenue for the quarter came in at $5.7 million, versus $6.1 million reported last year.
Adjusted EBITDA(1) (income from continuing operations adjusted for income taxes, other income and expense, interest, depreciation and... More
